The Intellipharmaceutics International Inc. (IPCI) Announces Quarterly Earnings Results, Meets Estimates

The Intellipharmaceutics International Inc. (IPCI) Announces Quarterly  Earnings Results, Meets Estimates

Intellipharmaceutics International Inc. (NASDAQ:IPCI) issued its quarterly earnings data on Friday. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). Intellipharmaceutics International had a negative net margin of 371.11% and a negative return on equity of 832.00%.

Shares of Intellipharmaceutics International (NASDAQ:IPCI) opened at 2.75 on Tuesday. The firm’s market capitalization is $79.05 million. Intellipharmaceutics International has a 12-month low of $1.41 and a 12-month high of $3.33. The firm’s 50-day moving average is $2.12 and its 200-day moving average is $1.87.

Several equities analysts have recently commented on the stock. Zacks Investment Research lowered shares of Intellipharmaceutics International from a “hold” rating to a “sell” rating in a report on Thursday, October 13th. Brean Capital set a $8.00 price objective on shares of Intellipharmaceutics International and gave the stock a “buy” rating in a report on Monday. Finally, Maxim Group set a $6.00 price objective on shares of Intellipharmaceutics International and gave the stock a “buy” rating in a report on Saturday.

About Intellipharmaceutics International

Related posts

Leave a Comment